Lajos Markó

6.2k citations
75 papers · 2.4k indexed · 1 hit paper · h-index 26

Impact in

Papers in

    • Chronic Kidney Disease and Diabetes 9
    • Renal Diseases and Glomerulopathies 6
    • Ion Channels and Receptors 6

Lajos Markó

69 papers receiving 2.4k citations

Hit Papers

Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients 2011 · 546 citations
5462011202620162021100200300400500

Peers

Lajos Markó
Comparison fields: 5 of 130
  • Geriatrics and Gerontology 296
  • Nephrology 335
  • Biochemistry 217
  • Physiology 589
  • Endocrinology, Diabetes and Metabolism 317
Replace Andrea Semplicini with:
Andrea Semplicini Italy
Yoon Sik Chang South Korea
Weixia Sun China
Cheol Whee Park South Korea
Elisa Pagnin Italy
Shu Wakino Japan
Joan Roselló‐Catafau Spain
Hana A. Itani United States
Evasio Pasini Italy
Seok Joon Shin South Korea
Lajos Markó relative to Andrea Semplicini Italy Andrea Semplicini's profile →
Citations per field
00.5×
Andrea Semplicini · 1×
Citations per year

Countries citing papers authored by Lajos Markó

Since Specialization
Citations

This map shows the geographic impact of Lajos Markó's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lajos Markó with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lajos Markó more than expected).

Fields of papers citing papers by Lajos Markó

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lajos Markó. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lajos Markó. The network helps show where Lajos Markó may publish in the future.

Co-authors

The 25 scholars most cited alongside Lajos Markó, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lajos Markó Line = papers co-authored together Lajos Markó links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20258
2 20251
3 20250
4 20235
5 202337
6 2021119
7 20212
8 202149
9 202013
10 201918
11 201931
12 201818
13 20146
14 201353
15 20114
16 20094
17
Apolipoprotein A5 gene APOA5*2 haplotype variant confers risk for the development of metabolic syndrome
20080
18 200750
19 20072
20 200544

About Lajos Markó

Lajos Markó is a scholar working on Nephrology, Sensory Systems, Biochemistry, Cardiology and Cardiovascular Medicine and Biological Psychiatry, having authored 75 papers that have together received 2.4k indexed citations. Recurring topics across this work include Gut microbiota and health (10 papers), Renin-Angiotensin System Studies (9 papers), Chronic Kidney Disease and Diabetes (9 papers), Blood Pressure and Hypertension Studies (8 papers), Nutritional Studies and Diet (7 papers), Renal Diseases and Glomerulopathies (6 papers), Eicosanoids and Hypertension Pharmacology (6 papers) and Ion Channels and Receptors (6 papers). The work is most often cited by research in Geriatrics and Gerontology (296 citations), Nephrology (335 citations), Biochemistry (217 citations), Physiology (589 citations) and Endocrinology, Diabetes and Metabolism (317 citations). Lajos Markó has collaborated with scholars based in Germany, Hungary and United States. Frequent co-authors include Dominik N. Müller, István Wittmann, István András Szijártó, Márton Mohás, G Molnár, Boglárka Laczy, Judit Cseh, Kai M. Schmidt‐Ott, Pál Brasnyó and László Mészáros. Their work appears in journals such as Hypertension, Acta Physiologica, Scientific Reports, Kidney International and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026